Aerska raised $21m recently for its RNA therapies tackling diseases like Alzheimer's. Co-founders Jack O’Meara and David Hardwicke talk to The Currency about what’s next.
Ochre Bio recently signed a deal with a German drugmaker to investigate potential treatments for chronic liver disease. Co-founder and CEO Jack O’Meara explains how it came about and what it means for his business.
The Carlow-based university spin-out harnessing bacteria to clean up polluted soils has just changed its name to Talam Biotech. Behind the scenes, the company has undergone a lot more than rebranding.
With a new US headquarters and a cross-Atlantic move on the horizon, Nuritas CEO and founder Dr Nora Khaldi discusses what led to the relocation and her plans for the next chapter of the company.
Having last year closed a $45m series B, Irish biotech company Nuritas has revealed it is building its new North American headquarters in Connecticut. CEO Dr Nora Khaldi is also moving to the US to lead the strategic expansion.
© 2026 Currency Media Limited
